Drug name - Ozurdex

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10702539 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US8506987 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US8034370 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US8034366 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US9192511 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US10076526 ALLERGAN Ocular implant made by a double extrusion process Jan, 2023

(3 months from now)

US6899717 ALLERGAN Methods and apparatus for delivery of ocular implants Nov, 2023

(1 year, 29 days from now)

Drugs and Companies using DEXAMETHASONE ingredient

Treatment: Treatment of diabetic macular edema; treatment of macular edema following branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo); treatment of non-infectious uveitis affecting the posterior segment of the eye; Treatment of macular edema; treatment of uveitis; Delivering an ocular implant as described in the dosage and administration section of the approved labeling of ozurdex

Dosage: IMPLANT;INTRAVITREAL

More Information on Dosage
Strength Dosage Availability
0.7MG IMPLANT;INTRAVITREAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.